End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)

Completed · Not applicable

Conditions studied: End Stage Liver Disease

In brief

The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)

Key facts

Study ID

NCT00374582

Run by

University of Cincinnati

People needed

30

Starts

2006-09-01

Expected to finish

2008-05-01

Last updated by the study team

2011-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with ESLD requiring LVP.
• Age over 18.
• Ability to provide written informed consent.

You may not qualify if…

• Organ retransplant candidates.
• Patient with use of any investigational agent within 30 days before LVP.
• Pregnant or lactating.
• Patients with non-bioprosthetic heart valves pacemakers, defibrillators, artificial joints, pins, plates, or other types of metal objects in the body.
• Amputations other than fingers or toes.

Where it is running

• University of Cincinnati — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.